Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Testing Treatment with Ipilimumab and Nivolumab Compared to Treatment with Ipilimumab Alone in Advanced Melanoma

This phase II trial studies how well ipilimumab with or without nivolumab work in treating patients with melanoma that is stage IV or stage III and cannot be removed by surgery. Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body’s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Melanoma
Phase II
Adults
Mol. targeted/Immunotherapy/Biologics
Ipilimumab, Nivolumab (BMS-936558)
Johnson, Douglas
National
Vanderbilt University
11-30-2018
Treatment
ECOGMELS1616
NCT03033576

Eligibility

18 Years
BOTH
NO

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: